1Korhonen H (2009) Milk-derived bioactive peptides: From science to applications. J Funct Foods 1, 177–187.
2Kelly D & Coutts APG (1997) Biologically active peptides in colostrum and milk. In Digestive Physiology in Pigs, pp. 163–170 [, editors]. Saint Malo, France: INRA.
3Meisel H (2005) Biochemical properties of peptides encrypted in bovine milk proteins. Curr Med Chem 12, 1905–1919.
4Moller NP, Scholz-Ahrens KE, Roos N, et al. (2008) Bioactive peptides and proteins from foods: indication for health effects. Eur J Nutr 47, 171–182.
5Hu WL, Mazurier J, Sawatzki G, et al. (1988) Lactotransferrin receptor of mouse small-intestinal brush border. Biochem J 249, 435–441.
6Guesdon B, Pichon L & Tomé D (2006) Opioid Peptides. In Nutraceutical Proteins and Peptides in Health and Disease, pp. 367–376 [, editors]. Boca Raton, Florida: CRC Press.
7Drescher K, Roos N, Pfeuffer M, et al. (1999) Recovery of 15N-Lactoferrin is higher than that of 15N-Casein in the small intestine of suckling, but not adult miniature pigs. J Nutr 129, 1026–1030.
8Roos N, Mahe S, Benamouzig R, et al. (1995) 15N-labeled immunoglobulins from bovine colostrum are partially resistant to digestion in human intestine. J Nutr 125, 11238–11244.
9Korhonen H & Marnila P (2006) Bovine milk antibodies for protection against microbial human disease. In Nutraceutical Proteins and Peptides in Health and Disease, pp. 137–159 [, editors]. Boca Raton, Florida: CRC Press.
10Korhonen H & Pihlanto A (2007) Technological options for the production of health-promoting proteins and peptides derived from milk and colostrum. Curr Pharm Des 13, 829–843.
11Baker EN, Baker HM, Koon N, et al. (2002) Lactoferrin: bioactive properties and applications. Bull Int Dairy Fed 375, 54–58.
12Baveye S, Elass E, Mazurier J, et al. (1999) Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin Chem Lab Med 37, 281–286.
13Elass E, Baveye S, Fernig D, et al. (2002) Lactoferrin interacts with CD14s and inhibits the expression of endothelial adhesion molecules, induced by the CD14s-lipopolysaccharide complex. Biochem Cell Biol 80, 165.
14Britton JR, George-Nasscimento C & Koldovsky O (1988) Luminal hydrolysis of recombinant human epidermal growth factor in the rat gastrointestinal tract: segmental and developmental differences. Life Sci 43, 1339–1347.
15Britton JR, George-Nasscimento C, Udall JN, et al. (1989) Minimal hydrolysis of epidermal growth factor by gastric fluid of preterm infants. Gut 30, 327–332.
16Read LC, Gale SM & George-Nascimento C (1987) Intestinal absorption of epidermal growth factor in newborn lambs. In Human Lactation 3 The effects of human milk on the recipient infant, pp. 199–204 [, editors]. New York: Plenum Press.
17Schusdziarra V, Schick A, De La Fuente A, et al. (1983) Effect of β-casomorphins and analogs on insulin release in dogs. Endocrinology 112, 885–889.
18Weaver LT (1997) Significance of bioactive substances in milk to the human neonate. Livestock Prod Sci 50, 139–146.
19Donnet-Hughes A, Duc N, Serrant P, et al. (2000) Bioactive molecules in milk and their role in health and disease: The role of transforming growth factor-β. Immunol Cell Biol 78, 74–79.
20Beattie RM, Schiffrin EJ, Donnet-Hughes A, et al. (1994) Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease. Aliment Pharmacol Ther 8, 609–615.
21Fell JM, Paintin M, Arnaud-Battandier F, et al. (2000) Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther 14, 281–289.
22Ozawa T, Miyata M, Nishimura M, et al. (2009) Transforming growth factor-β activity in commercially available pasteurized cow milk provides protection against inflammation in mice. J Nutr 139, 69–75.
23Schriffin E, El Yousfi M, Faure M, et al. (2005) Milk casein-based diet containing TGF-β controls the inflammatory reaction in the HLA-B27 transgenic rat model. J Parent Enteral Nutr 29, S141–S148.
24Neurath MF, Fuss I, Kelsall BL, et al. (1996) Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med 183, 2605–2616.
25Sanchez de Medina F, Daddaoua A, Requena P, et al. (2010) New insights into the immunological effects of food bioactive peptides in animal models of intestinal inflammation. Proc Nutr Soc 69, 454–462.
26Pellegrini A (2003) Antimicrobial peptides from food proteins. Curr Pharma Design 9, 1225–1238.
27Teschemacher H (2003) Opioid receptor ligands derived from food proteins. Curr Pharma Design 9, 1331–1344.
28Moughan PJ, Fuller MF, Han K-S, et al. (2007) Food-derived bioactive peptides influence gut function. Int J Sport Nutr Exerc Metab 17, S5–S22.
29Yoshimoto R, Fischl M, Orlowski RC, et al. (1978) Post-proline cleaving enzyme and post-proline dipeptidyl amino-peptidase comparison of two peptidases with high specificity for proline residues. J Biol Chem 253, 3708–3716.
30Mock LW, Green PC & Boyer KD (1990) Specificity and pH dependence for acylproline cleavage by prolidase. J Biol Chem 265, 19600–19605.
31Naito H & Suzuki H (1974) Further evidence for the formation in vivo of phosphopeptide in the intestinal lumen from dietary β-casein. Agr Biol Chem 38, 1543–1545.
32Kitts DD, Yuan YV, Nagasawa T, et al. (1992) Effect of casein, casein phosphopeptides and calcium intake on ileal 45Ca disappearance and temporal systolic blood pressure in spontaneously hypertensive rats. Br J Nutr 68, 765–781.
33Kasai T, Honda T & Kiriyama S (1992) Caseinphosphopeptides (CPP) in feces of rats fed casein diet. Biosci Biotech Biochem 56, 1150–1151.
34Adibi SA & Morse EL (1971) Intestinal transport of dipeptides in man: relative importance of hydrolysis and intact absorption. J Clin Invest 50, 2266–2275.
35Hara H, Funabiki R, Iwata M, et al. (1984) Portal absorption of small peptides in rats under unrestrained conditions. J Nutr 114, 1122–1129.
36Bloch KJ, Wright JA, Bishara SM, et al. (1988) Uptake of polypeptide fragments of proteins by rat intestine in vitro and in vivo. Gastroenterology 95, 1272–1278.
37Chabance B, Marteau P, Rambaud JC, et al. (1998) Casein peptide release and passage to the blood in humans during digestion of milk or yogurt. Biochimie 80, 155–165.
38Fosset S, Fromentin G, Gietzen DW, et al. (2002) Peptide fragments released from Phe-caseinmacropeptide in vivo in the rat. Peptides 23, 1773–1781.
39Nakamura Y, Masuda O & Takano T (1996) Decrease of tissue angiotensin I-converting enzyme activity upon feeding sour milk to spontaneously hypertensive rats. Biosci Biotech Biochem 60, 488–489.
40Masuda O, Nakamura Y & Takano T (1996) Antihypertensive Peptides Are Present in Aorta after Oral Administration of Sour Milk Containing These Peptides to Spontaneously Hypertensive Rats. J Nutr 126, 3063–3068.
41Satake M, Enjoh M, Nakamura Y, et al. (2002) Transepithelial Transport of the Bioactive Tripeptide, Val-Pro-Pro, in Human Intestinal Caco-2 Cell Monolayers. Biosci Biotechnol Biochem 66, 378–384.
42Yokoyama K, Chiba H & Yoshikawa M (1992) Peptide inhibitors for angiotensin I-converting enzyme from thermolysin digest of dried bonito. Biosci Biotech Biochem 56, 1541–1545.
43Fujita H, Yokoyam K & Yoshikawa M (2000) Classification and antihypertensive activity of angiotensin I-converting enzyme inhibitory peptides derived from food proteins. J Food Sci 65, 564–569.
44Hata Y, Yamamoto M, Ohni M, et al. (1996) A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr 64, 767–771.
45Yoshikawa M, Fujita H, Matoba N, et al. (2000) Bioactive peptides derived from food proteins preventing lifestyle-related diseases. Biofactors 12, 143–146.
46Gilani GS, Xiao C & Lee N (2008) Need for accurate and standardized determination of amino acids and bioactive peptides for evaluating protein quality and potential health effects of foods and dietary supplements. JOAC Int 91, 894–900.
47Carroll KK (1978) The role of dietary protein in hypercholesterolemia and atherosclerosis. Lipids 13, 360–365.
48Anderson JW, Johnstone BM & Cook-Newell ME (1995) Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids. N Eng J Med 333, 276–282.
49Sugano M, Yamada Y, Yoshihida K, et al. (1988) The hypocholesterolemic action of the undigested fraction of soybean protein in rats. Atherosclerosis 72, 115–122.
50Cho S-J, Juillerat MA & Lee C-H (2007) Cholesterol lowering mechanism of soybean protein hydrolysate. J Agric Food Chem 55, 10599–10604.
51Morley JE, Levine AS, Yamada T, et al. (1983) Effect of exorphins on gastrointestinal function, hormonal release and appetite. Gastroenterology 84, 1517–1523.
52Meisel H & Frister H (1989) Chemical characterization of bioactive peptides from in vivo digests of casein. J Dairy Res 56, 343–349.
53Brantl V, Teschemacher H, Henschen A, et al. (1979) Novel opioid peptides derived from casein (beta-casomorphins). II. Structure of active components from bovine casein peptone. Hoppe-Seyler's Z Physiol Chem 360, 1211–1216.
54Brantl V (1984) Novel opioid peptides derived from human beta-casein: human beta-casomorphins. Eur J Pharmacol 106, 213–214.
55Teschemacher H, Koch G & Brantl V (1997) Milk protein-derived opioid receptor ligands. Biopoly 43, 99–117.
56Brantl V, Gramsch C, Lottspeich F, et al. (1986) Novel opioid peptides derived from hemoglobin: hemorphins. Eur J Pharmacol 125, 309–310.
57Meisel H & Schlimme E (1990) Milk proteins: precursors of bioactive peptides. Trends Food Sci Technol 1, 41–43.
58Pihlanto-Leppälä A (2001) Bioactive peptides derived from bovine whey proteins: opioid and ace-inhibitory peptides. Trends Food Sci Technol 11, 347–356.
59Yoshikawa M, Tani F, Yoshimura T, et al. (1986) Opioid Peptides from Milk Proteins. Agric Biol Chem 50, 2419–2421.
60Yoshikawa M, Tani F & Chiba H (1988) Structure-activity relationship of opioid antagonist peptides derived from milk proteins. In Peptide Chemistry, pp. 473–476 [, editor]. Osaka: Protein Research Foundation.
61Clare DA & Swaisgood HE (2000) Bioactive milk peptides: A prospectus. J Dairy Sci 83, 1187–1195.
62Meisel H (1998) Overview on milk protein-derived peptides. Int Dairy J 8, 363–373.
63Meisel H (1986) Chemical characterization and opioid activity of an exorphin isolated from in vivo digests of casein. FEBS Lett 196, 223–227.
64Svedberg J, de Haas J, Leimenstoll G, et al. (1985) Demonstration of β-casomorphin immunoreactive materials in in vitro digests of bovine milk and in small intestine contents after bovine milk ingestion in adult humans. Peptides 6, 825–830.
65Singh M, Rosen CL, Chang KJ, et al. (1989) Plasma [beta]-casomorphin-7 immunoreactive peptide increases after milk intake in newborn but not in adult dogs. Pediatr Res 26, 34–38.
66Hamel V, Kielwein G & Teschemacher H (1985) β-Casomorphin immunoreactive materials in cows' milk incubated with various bacterial species. J Dairy Res 52, 139–148.
67Lin L, Umahara M, York DA, et al. (1998) β-Casomorphins stimulate and enterostatin inhibits the intake of dietary fat in rats. Peptides 19, 325–331.
68Hedner J & Hedner T (1987) β-casomorphins induce apnea and irregular breathing in adult rats and newborn rabbits. Life Sci 41, 2303–2312.
69Pasi A, Mahler H, Lansel N, et al. (1993) Res Commun Chem Pathol Pharmacol 80, 305–322.
70Fukudome S-I & Yoshikawa M (1992) Opioid peptides derived from wheat gluten: Their isolation and characterization. FEBS Lett 296, 107–111.
71Fukudome S-I & Yoshikawa M (1993) Gluten exorphin C: A novel opioid peptide derived from wheat gluten. FEBS Lett 316, 17–19.
72Fukudome S-I, Shimatsu A, Suganuma H, et al. (1995) Effect of gluten exorphins a5 and b5 on the postprandial plasma insulin level in conscious rats. Life Sci 57, 729–734.
73Glämsta E-L, Marklund A, Hellman U, et al. (1991) Isolation and characterization of a hemoglobin-derived opioid peptide from the human pituitary gland. Regul Pept 34, 169–179.
74Piot J-M, Zhao Q, Guillochon D, et al. (1992) Isolation and characterization of two opioid peptides from a bovine hemoglobin peptic hydrolysate. Biochem Biophys Res Commun 189, 101–110.
75Zadina JE, Kastin AJ, Kersh D, et al. (1992) Tyr-MIF-1 and hemorphin can act as opiate agonists as well as antagonists in the guinea pig ileum. Life Sci 51, 869–885.
76Davis TP, Gillespie TJ & Porreca F (1989) Peptide fragments derived from the β-chain of hemoglobin (hemorphins) are centrally active in vivo. Peptides 10, 747–751.
77Nyberg F, Sanderson K & Glämsta E-L (1997) The hemorphins: a new class of opioid peptides derived from the blood protein hemoglobin. Biopoly 43, 147–156.
78Ivanov VT, Karelin AA, Philippova MM, et al. (1997) Hemoglobin as a source of endogenous bioactive peptides: the concept of tissue-specific peptide pool. Biopoly 43, 171–188.
79Schanbacher FL, Talhouk RS, Murray FA, et al. (1998) Milk-Borne Bioactive Peptides. Int Dairy J 8, 393–403.
80Shahidi F & Zhong Y (2008) Bioactive peptides. JOAC Int 91, 914–931.
81Kitts DD (1994) Bioactive substances in food: identification and potential uses. Can J Physiol Pharmacol 72, 423–434.
82Naito H, Kawakami A & Inamura T (1972) In vivo formation of phosphopeptide with calcium-binding property in the small intestinal tract of the rat fed on casein. Agric Biol Chem 36, 409–415.
83Sato R, Noguchi T & Naito H (1983) The necessity for the phosphate portion of casein molecules to enhance Ca absorption from the small intestine. Agric Biol Chem 47, 2415–2417.
84Yuan YV & Kitts DD (1991) Confirmation of calcium absorption and femoral utilization in spontaneously hypertensive rats fed casein phosphopeptide supplemented diets. Nutr Res 11, 1257–1272.
85Scholz-Ahrens KE, de Vrese M & Barth CA (1991) Influence of casein-derived phosphopeptides on the bioavailability of calcium in vitamin D-deficient miniature pigs. In Gene regulation, structure-function analysis and clinical application, pp. 724–725 [, editors]. Berlin: W de Gruyter.
86Hansen M, Sandstöm B, Jensen M, et al. (1997) Casein phosphopeptides improve zinc and calcium absorption from rice-based but not from whole-grain infant cereal. J Pediatr Gastroenterol Nutr 24, 56–62.
87Narva M, Karkkainen M, Poussa T, et al. (2003) Caseinphosphopeptides in milk and fermented milk do not affect calcium metabolism acutely in postmenopausal women. J Am Coll Nutr 22, 88–93.
88Uenishi K, Ishida H, Toba Y, et al. (2007) Milk basic protein increases bone mineral density and improves bone metabolism in healthy young women. Osteoporos Int 18, 385–390.
89Aoe S, Koyama T, Toba Y, et al. (2005) A controlled trial of the effect of milk basic protein (MBP) supplementation on bone metabolism in healthy menopausal women. Osteoporos Int 16, 2123–2128.
90Toba Y, Takada Y, Yamamura J, et al. (2000) Milk basic protein: a novel protective function of milk against osteoporosis. Bone 27, 403–408.
91Foltz M, van der Pijl PC & Duchateau GSMJE (2010) Current in vitro testing of bioactive peptides is not valuable. J Nutr 140, 117–118.
92Fujita H, Yokoyama K & Yoshikawa M (2000) Classification and antihypertensive activity of angiotensin I-converting enzyme inhibitory peptides derived from food proteins. J Food Sci 65, 564–569.
93Rutherfurd-Markwick KJ & Moughan PJ (2005) Bioactive peptides derived from food. JOAC Int 88, 955–966.
94Del Mar Contreras M, Lopez-Exposito I, Hernandez-Ledesma B, et al. (2008) Application of mass spectrometry to the characterization and quantification of food-derived bioactive peptides. JOAC Int 91, 981–994.
95Sato K, Iwai K & Aito-Inoue M (2008) Identification of food-derived bioactive peptides in blood and other biological samples. JOAC Int 91, 995–1001.